NON-VAL30MET-TRANSTHYRETIN AMYLOID CARDIOMYOPATHY. LITERATURE REVIEW AND CLINICAL CASE

QR Code

NON-VAL30MET-TRANSTHYRETIN AMYLOID CARDIOMYOPATHY. LITERATURE REVIEW AND CLINICAL CASE

A literature review presented, with a clinical observation of non-Val30Mettransthyretin amyloid cardiomyopathy. Modern diagnostic and management algorithms discussed.

Saved in:

Bibliographic Details
Main Authors:	A. Ya. Gudkova, A. A. Poliakova, А. V. Amelin, O. М. Moiseeva, А. N. Krutikov, V. М. Tishkova, R. V. Grozov, D. V. Ryzhkova, T. V. Makurova, A. A. Kostareva, E. N. Semernin, E. V. Shlyakhto
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2018-03-01
Series:	Российский кардиологический журнал
Subjects:	genetic transthyretin amyloidosis transthyretin amyloid cardiomyopathy val30met mutation
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2537
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Proteomic Analysis of Serum in Cardiac Transthyretin Amyloidosis: Diagnostic and Prognostic Implications for Biomarker Discovery
by: Joanna Waś, et al.
Published: (2025-07-01)

Molecular Dynamics Simulation Study of Stabilizer Association with the Val122Ile Transthyretin Variant
by: Kevin Morris, et al.
Published: (2025-04-01)

Transthyretin is a promising prognostic marker of non-developing pregnancy in hypothyroidism
by: A. A. Orazmuradov, et al.
Published: (2024-12-01)

A Clinical Case of the Hereditary Transthyretin Amyloidosis
by: E. V. Reznik, et al.
Published: (2021-05-01)

Hereditary transthyretin amyloidosis
by: T. A. Adyan, et al.
Published: (2020-01-01)

Hereditary systemic transthyretin amyloidosis: a clinical case and an opinion on the problem
by: A. S. Draganova, et al.
Published: (2019-07-01)

Unravelling the myriad physiologic roles of transthyretin: critical considerations for treating transthyretin amyloidosis
by: Morie A. Gertz, et al.
Published: (2025-12-01)

Phenotypic heterogeneity and diagnostic features of transthyretin amyloidosis with polyneuropathy
by: S. S. Nikitin, et al.
Published: (2021-12-01)

Systemic transthyretin amyloidosis: carpal tunnel syndrome in a Portuguese population (CarPoS)
by: Sofia Pimenta, et al.
Published: (2024-10-01)

Advances in understanding, diagnosis and targeting ATTR cardiomyopathy: a review
by: Maria Kulak, et al.
Published: (2024-06-01)

CT derived ECV in severe aortic stenosis: prognosticator and screening test for co-existent transthyretin cardiac amyloidosis
by: Joshua N. McShane, et al.
Published: (2025-08-01)

Effects of the COMT Val158Met polymorphism on N100 component of auditory evoked potential and oddball task performance in healthy subjects and schizophrenia patients
by: A. A. Fedotova, et al.
Published: (2019-12-01)

Unraveling gut microbiome alterations and metabolic signatures in hereditary transthyretin amyloidosis
by: Hanyu Li, et al.
Published: (2025-07-01)

Misdiagnosed case of transthyretin amyloidosis in a fully investigated patient
by: E. S. Naumova, et al.
Published: (2018-04-01)

New QSAR Models to Predict Human Transthyretin Disruption by Per- and Polyfluoroalkyl Substances (PFAS): Development and Application
by: Marco Evangelista, et al.
Published: (2025-07-01)

Secretion of transthyretin: molecular mechanisms dependent on the endoplasmic reticulum
by: Jia Meng, et al.
Published: (2025-07-01)

BDNF Val66Met polymorphism moderates associations between physical activity and neurocognitive outcomes in older adults
by: Claire J. Cadwallader, et al.
Published: (2025-04-01)

Early identification of cardiac ATTR amyloidosis: a clinical case
by: A. A. Vedernikov, et al.
Published: (2024-07-01)

Amyloid cardiomyopathy: сlinical significance and diagnostic value of magnetic resonance imaging
by: M. V. Ezhikova, et al.
Published: (2024-11-01)

The Role of Three Plasma Proteins in the Diagnosis of Ovarian Tumors
by: Valeria Racheva, et al.
Published: (2022-06-01)

Delays in diagnosis and treatment of ATTR cardiac amyloidosis: A real‐world data analysis
by: Julia Vogel, et al.
Published: (2025-08-01)

Familial amyloid polyneuropathy TTR Cys 114 in monozygotic twin brothers (clinical case)
by: M. O. Kovalchuk, et al.
Published: (2017-05-01)

A new era in treatment of cardiac amyloidosis: an overview of the Congress of cardiology
by: I. E. Strelkova
Published: (2022-01-01)

Phenotypic Presentation and Longitudinal Characterization of Hereditary ATTRv Amyloidosis in Previously Undiagnosed Family Members
by: Luca Fazzini, MD, et al.
Published: (2025-08-01)

Diagnostic pathway for cardiac amyloidosis from the healthcare professional’s perspective: results from the French DIAM-ATTR survey
by: Silvia Oghina, et al.
Published: (2025-12-01)

Differential Diagnosis of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
by: M. S. Bychkova, et al.
Published: (2023-10-01)

Entre valses y bandas: Una conversación con Virginia Yep sobre el vals criollo y la música del Bajo Piura
by: Luis Andrés Cáceres Álvarez
Published: (2025-06-01)

Investigating proactive measures towards MET development with respect to 4IR
by: Hossam Eldin Hassan Gadalla
Published: (2022-12-01)

Equity valuation and analysis with eVal /
by: Lundholm, Russell ; Sloan, Richard
Published: (2004)

Systemic ATTR-amyloidosis, a Rare Form of Internal Organ Damage
by: V. V. Rameev, et al.
Published: (2019-07-01)

Bilateral segmentectomies using virtual-assisted lung mapping (VAL-MAP) for metastatic lung tumors
by: Keita Nakao, et al.
Published: (2017-09-01)

CMV-infection in patients after liver transplantation
by: M. Sh. Khubutiya, et al.
Published: (2016-02-01)

Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT/ERK1/2-EGR1 pathway
by: Qing-Feng Xiang, et al.
Published: (2019-12-01)

Patients with Papillary Renal Cancer and Germline Duplication of <i>MET</i> Exons 5-21
by: Dmitry S. Mikhaylenko, et al.
Published: (2025-05-01)

Review of real-world studies on capmatinib use in MET-mutated lung cancer
by: A. A. Kurylev, et al.
Published: (2025-04-01)

QUANTITATIVE RHOA Gly17Val ALLELE-SPECIFIC POLYMERASE CHAIN REACTION AND T-CELL CLONALITY ANALYSIS IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
by: Yu. V. Sidorova, et al.
Published: (2018-02-01)

Fexofenadine Overcomes Osimertinib Resistance by Inhibiting c‐Met in Non‐Small Cell Lung Cancer
by: Kenneth K. W. To, et al.
Published: (2025-06-01)

MetInfilt: A prospective trial highlighting the importance of the histological growth pattern in brain metastases
by: Martin A. Proescholdt, et al.
Published: (2025-10-01)

The clinical use of the MOGE(S) classification in the differential diagnosis between idiopathic hypertrophic cardiomyopathy and its phenocopies
by: A. Poliakova, et al.
Published: (2019-11-01)

A Phase II Study of Cabozantinib in Patients With MET-Altered Lung Cancers
by: Guilherme Harada, MD, et al.
Published: (2025-08-01)